Radiomics in Pancreatic Cancer

Radiomics-based Detection and Outcome Prediction for Pancreatic Cancer

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05658679

Enrollment

2000

Registered

2022-12-21

Start date

2016-01-31

Completion date

2024-12-31

Last updated

2022-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer

Brief summary

The images of patients with pancreatic cancer were collected and analyzed based on the methodes of radiomics

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

* Gender unlimited, 18-80 years old; * Received abdominal imaging; * informed consent signed.

Exclusion criteria

* Pregnant / lactating women； * Contraindications of imaging examination。

Design outcomes

Primary

Measure	Time frame
5-year survival rate	1 week

Outcome results